MedPath

HANDLING USI20 Study: Satisfaction assessment and Good Usage Practice of RS01® versus Handihaler® inhalers in patients with COPD, a randomized comparative multicenter study

Phase 3
Conditions
Respiratory
Registration Number
PACTR202008893896971
Lead Sponsor
OPALIA pharma RECORDATI Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
87
Inclusion Criteria

Age ? 18 years old
Informed consent, read and signed
Patient with COPD
No previous use of any of the study devices

Exclusion Criteria

Consent not signed

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A satisfaction questionnaire was developped based on 20 items and administrated to the population study after using of the RS1 or the Handihaler inhalers. The primary endopoint is a quantitative criterion defined by of the number of subjects who had a final score = 80% iassessment questionnaires.
Secondary Outcome Measures
NameTimeMethod
Mean score of the satisfaction questionnaire for each trial group
© Copyright 2025. All Rights Reserved by MedPath